Methylcyclopentadienyl manganese tricarbonyl: Health risk uncertainties and research directions

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 1, 1998, Pages 191-201

  Davis, J Michael ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Exposure assessment; Fuel additive; Inhalation health effects; Manganese; MMT; Reference concentration; Risk assessment

Indexed keywords

GASOLINE; MANGANESE DERIVATIVE; METHYLCYCLOPENTADIENYLMANGANESE TRICARBONYL; UNCLASSIFIED DRUG;

AIR POLLUTANT; AIRBORNE PARTICLE; ENVIRONMENTAL PROTECTION; HEALTH HAZARD; HUMAN; INHALATION; POPULATION EXPOSURE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; UNITED STATES;

EID: 0031956910     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106s1191     Document Type: Review

References (106)

1. ter Haar GL, Lenane DL, Hu JN, Brandt M. Composition, size and control of automotive exhaust particulates. J Air Pollut Control Assoc 22:39-46 (1972).
2. Piver WT. Potential dilemma: the methods of meeting automotive exhaust emission standards of the Clean Air Act of 1970. Environ Health Perspect 8:165-190 (1974).
3. U.S. Congress. Clean Air Act Amendments of 1977. PL 95-95. Washington:U.S. Government Printing Office, 1977.
4. Ethyl Corporation. MMT Q & A. Richmond, VA:Ethyl Corporation, 1997 [Online]. Available from www.ethyl.com/ mmtqa.html.
5. U.S. Environmental Protection Agency. Fuels and fuel additives; waiver decision/circuit court remand. Fed Reg 59:42227-42247 (1994).
6. Ethyl Corporation v. the U.S. Environmental Protection Agency, CA DC, 94-1505, 51 F3d, 1995.
7. U.S. Environmental Protection Agency. Fuels and fuel additives registration regulations; final rule. Fed Reg 59:33042-33142 (1994).
8. Ethyl Corporation v. the U.S. Environmental Protection Agency, CA DC, 94-1516, 67 F3d 941, 1995.
9. Urquhart J. Canada's House of Commons is expected to vote for Dan on ethyl fuel additive. Wall Street J October 28:B6A (1996).
10. Menkes DB, Fawcett JP. Too easily lead? Health effects of gasoline additives. Environ Health Perspect 105:270-273 (1997).
11. U.S. Congress. Clean Air Act Amendments of 1990. PL 101-549. Washington:U.S. Government Printing Office, 1990.
12. Silbergeld EK. Hazards of manganese as an additive in vehicle fuel. In: International Conference: Heavy Metals in the Environment, Vol 2, September, New Orleans, LA (Lindberg SE, Hutchinson TC, eds). Edinburgh:CEP Consultants, 1987;1.
13. Davis JM, Elias RW, Grant LD. Efforts to reduce lead exposure in the United States, In: Mineral and Metal Neurotoxicology (Yasui M, Strong MJ, Ota K, Verity MA, eds). Boca Raton, FL: CRC Press, 1996;285-293.
14. Garrison AW, Cipollone MG, Wolfe NL, Swank RR Jr. Environmental fate of methylcyclopentadienyl manganese tricarbonyl. Environ Toxicol Chem 14:1859-1864 (1995).
15. U.S. Environmental Protection Agency. (1995, November). Oral reference dose (RfD) for manganese. In: IRIS (Integrated Risk Information System) [Database Online]. Available from www.epa.gov/ngispgm3/iris/index.html
16. Couper J. On the effects of black oxide of maganese when inhaled into the lungs. Br Ann Med Pharm 1:41-42 (1837).
17. Aschner M, Aschner JL. Manganese neurotoxicity: cellular effects and blood-brain barrier transport. Neurosci Biobehav Rev 15:333-340 (1991).
18. Murphy VA, Wadhwani KG, Smith QR, Rapoport SI. Saturable transport of manganese(II) across the rat blood-brain barrier. J Neurochem 57:948-954 (1991).
19. Rabin O, Hegedus L, Bourre J-M, Smith QR. Rapid brain uptake of manganese(II) across the blood-brain barrier. J Neurochem 61:509-517 (1993).
20. Tjälve H, Henriksson J, Tallkvist J, Larsson BS, Lindquist NG. Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacol Toxicol 79:347-356 (1996).
21. ter Haar GL, Griffing ME, Brandt M, Oberding DG, Kapron M. Methylcyclopentadienyl manganese tricarbonyl as an antiknock: composition and fate of manganese exhaust products. In: 67th Annual Meeting of the Air Pollution Control Association, 9-13 June, Denver, Colorado. Pittsburgh, PA:Air Pollution Control Association, 1974.
22. National Research Council. Risk Assessment in the Federal Government: Managing the Process. Washington:National Academy Press, 1983.
23. U.S. EPA. Reevaluation of Inhalation Health Risks Associated with Methylcyclopentadienyl Manganese Tticatbonyl (MMT) in Gasoline [Final]. EPA/600/R-94/062. Washington:U.S. Environmental Protection Agency, 1994.
24. Rodier J. Manganese poisoning in Moroccan miners. Br J Ind Med 12:21-35 (1955).
25. Cotzias GC, Horiuchi K, Fuenzalida S, Mena I. Chronic manganese poisoning: clearance of tissue manganese concentrations with persistence of the neurological picture. Neurology 18:376-382 (1968).
26. Barbeau A. Etiology of Parkinson's disease: a research strategy. Can J Neurol Sci 11:24-28 (1984).
27. Wolters EC. Manganese-induced parkinsonism. In: Mineral and Metal Neurotoxicology (Yasui M, Strong MJ, Ota K, Verity MA, eds). Boca Raton, FL:CRC Press, 1996;319-325.
28. Calne DB, Chu N-S, Huang C-C, Lu C-S, Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 44:1583-1586 (1994).
29. Yamada M, Ohno S, Okayasu I, Okeda R, Hatakeyama S, Watanabe H, Ushio K, Tsukagoshi H. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol 70:273-278 (1986).
30. Newland MC, Weiss B. Persistent effects of manganese on effortful responding and their relationship to manganese accumulation in the primate globus pallidus. Toxicol Appl Pharmacol 113:87-97 (1992).
31. Shinotoh H, Snow BJ, Hewitt KA, Pate BD, Doudet D, Nugent R, Perl DP, Olanow W, Calne DB. MRI and PET studies of manganese-intoxicated monkeys. Neurology 45:1199-1204 (1995).
32. Bird ED, Anton AH, Bullock B. The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkey. Neurotoxicology 5:59-65 (1984).
33. Eriksson H, Tedroff J, Thuomas K-A, Aquilonius S-M, Hartvig P, Fasth K-J, Bjurling P, Långström B, Hedström K-G, Heilbronn E. Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging. Arch Toxicol 66:403-407 (1992).
34. Heilbronn E, Eriksson H. Implications of manganese in disease, especially central nervous system disorders. In: Mineral and Metal Neurotoxicology (Yasui M, Strong MJ, Ota K, Verity MA, eds). Boca Raton, FL:CRC Press, 1996;311-317.
35. Wolters EC, Huang C-C, Clark C, Peppard RF, Okada J, Chu N-S, Adam MJ, Ruth TJ, Li D, Calne DB. Positron emission tomography in manganese intoxication. Ann Neurol 26:647-651 (1989).
36. 2+ sequestration by mitochondria and inhibition of oxidative phosphorylation. Toxicol Appl Pharmacol 115:1-5 (1992).
37. Brouiller EP, Shinobu L, McGarvey U, Hochberg F, Beal MF. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp Neurol 120:89-94 (1993).
38. Saric M. Occupational and environmental exposures and nonspecific lung disease-a review of selected studies. Isr J Med Sci 28:509-512 (1992).
39. Roels H, Lauwerys R, Buchet J-P, Genet P, Sarhan MJ, Hanotiau I, de Fays M, Bernard A, Stanescu D. Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am J Ind Med 11:307-327 (1987).
40. Nogawa K, Kobayashi E, Sakamoto M, Fukushima N, Ishizaki A, Makino N, Kagamimori S, Hiramaru Y, Kawano S, Kato T et al. Studies of the effects on the respiratory organs of air pollution consisting of dusts composed mainly of manganese (first report). Effects on the respiratory organs of junior high school students. Nippon Koshu Eisei Zasshi 20:315-325 (1973).
41. Cook DG, Fahn S, Brait KA. Chronic manganese intoxication. Arch Neurol 30:59-64 (1974).
42. Lauwerys R, Roels H, Genet P, Toussaint G, Bouckaert A, De Cooman S, Fertility of male workers exposed to mercury vapor or to manganese dust: a questionnaire study. Am J Ind Med 7:171-76(1985).
43. Deskin R, Bursian SJ, Edens FW. The effect of chronic manganese administration on some neurochemical and physiological variables in neonatal rats. Gen Pharmacol 12:279-280 (1981).
44. U.S. Environmental Protection Agency. (1988, September). CRAVE cancer assessment for manganese. In: IRIS (Integrated Risk Information System) [Database Online]. Available from www. epa.gov/ngispgm3/iris/index.html
45. Roels HA, Ghyselen P, Buchet JP, Ceulemans E, Lauwerys RR. Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br J Ind Med 49:25-34 (1992).
46. U.S. Environmental Protection Agency (1990, December). Inhalation reference concentration (RfC) for manganese. In: IRIS (Integrated Risk Information System) [Database Online]. Available from www. epa.gov. ngispgm3/iris/index.html
47. U.S. Environmental Protection Agency (1993, December). Inhalation reference concentration (RfC) for manganese. In: IRIS (Integrated Risk Information System) [Database Online]. Available from www.epa.gov.ngispgm3/iris/index.html
48. Mergler D, Huel G, Bowler R, Iregren A, Belanger S, Baldwin M, Tardif R, Smargiassi A, Martin L. Nervous system dysfunction among workers with long-term exposure to manganese. Environ Res 64:151-180 (1994).
49. Iregren A. Psychological test performance in foundry workers exposed to low levels of manganese. Neurotoxicol Teratol 12:673-675 (1990).
50. Lucchini R, Sells L, Folli D, Apostoli P, Mutti A, Vanoni O, Iregren A, Alessio L. Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand J Work Environ Health 21:143-149 (1995).
51. American Conference of Governmental Industrial Hygienists. 1996 TLVs and BEIs: Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati, OH:American Conference of Governmental Industrial Hygienists, 1992;40-45.
52. Roels H. Attachment A-l: individual exposure and dichotomized response data of Roels (1993). In: Reevaluation of Inhalation Health Risks Associated with Methylcyclopentadienyl Manganese Tricarbonyl (MMT) in Gasoline [Final]. EPA/600/R-94/062. Washington:U.S. Environmental Protection Agency, 1994;A-66-A68.
53. Crump KS. A new method for determining allowable daily intakes. Fundam Appl Toxicol 4:854-871 (1984).
54. Hasselblad V, Jarabek AM. Dose-response analysis of toxic chemicals. In: Bayesian Biostatistics (Berry DA, Stangl DK, eds). NewYork:Marcel Dekker, 1994;235-259.
55. Davis JM, Jarabek A, Mage DT, Graham JA. The EPA health. risk assessment of methylcyclopentadienyl manganese tricarbonyl (MMT). Risk Anal (in press).
56. Clayton CA, Perritt RL, Pellizzari ED, Thomas KW, Whitmore RW, Wallace LA, Özkaynak H, Spengler JD. Particle total exposure assessment methodology (PTEAM) study: distributions of aerosol and elemental concentrations in personal, indoor, and outdoor air samples in a southern California community. J Exposure Anal Environ Epidemiol 3:227-250 (1993).
57. Lynam DR, Pfeifer GD, ter Haar GL, Fort BF. Exposures to manganese-in-air in an urban environment. In: Trace Substances in Environmental Health: Proceedings of the 27th Annual Conference of the Society of Environmental Geochemistry and Health, July 1993, New Orleans, Louisiana (Cothern, CR, ed). Northwood, United Kingdom:Science Reviews, 1994;21-29.
58. Zayed J, Gerin M, Loranger S, Sierra P, Begin D, Kennedy G. Occupational and environmental exposure of garage workers and taxi drivers to airborne manganese arising From the use of methylcyclopentadienyl manganese tricarbonyl in unleaded gasoline. Am Ind Hyg Assoc J 55:53-58 (1994).
59. Kirshenblatt M. Unpublished data.
60. Loranger S, Zayed J, Forget E. Manganese contamination in Montreal in relation with traffic density. Water Air Soil Pollut 74:385-396 (1994).
61. Lytle CM, Smith BN, McKinnon CZ. Manganese accumulation along Utah roadways: a possible indication of motor vehicle exhaust pollution. Sci Total Environ 162:105-109 (1995).
62. Pellizzari ED, Thomas KW, Clayton CA, Whitmore RW, Shores RC, Zelon HS, Perritt RL. Particle Total Exposure Assessment Methodology (PTEAM): Riverside, California, Pilot Study. Vol I [Final Report]. EPA/600/R-93/050. Research Triangle Park, NC:U.S. Environmental Protection Agency, 1992.
63. Lönnerdal B. Dietary factors affecting trace element absorption in infants. Acta Paediatr Scand Suppl 351:109-113 (1989).
64. Fell JME, Reynolds AP, Meadows N, Khan K, Long SG, Quaehebeur G, Taylor WJ, Milla PJ. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 347:1218-1221 (1996).
65. Wilson DC, Tubman R, Bell N, Halliday HL,McMaster D. Plasma manganese, selenium and glutathione peroxidase levels in the mother and newborn infant. Early Hum Dev 26:223-226(1991).
66. Tholin K, Sandström B, Palm R, Hallmans G. Changes in blood manganese levels during pregnancy in iron supplemented and non supplemented women. J Trace Elem Med Biol 9:13-17 (1995).
67. Kawamura R, Ikuta H, Fukuzumi S, Yamada R, Tsubaki S, Kodama T, Kurata S. Intoxication by manganese in well water. Kitasato Arch Exp Med 18:145-169 (1941).
68. Mena I, Horiucni K, Burke K, Cotzias GC. Chronic manganese poisoning: individual susceptibility and absorption of iron. Neurology 19:1000-1006(1969).
69. Davidsson L, Cederblad A, Lönnerdal B, Sandström B. The effect of individual dietary components on manganese absorption in humans. Am J Clin Nutr 54:1065-1070 (1991).
70. Hauser RA, Zesiewicz TA, Martinez C, Rosemurgy AS, Olanow CW. Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can J Neurol Sci 23:95-98 (1996).
71. Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopa- thy. Lancet 346:270-274 (1995).
72. Davis JM, Grant LD. The sensitivity of children to lead. In: Similarities and Differences Between Children and Adults: Implications for Risk Assessment (Guzelian PS, Henry CJ, Olin SS, eds). Washington:International Life Sciences Institute Press, 1992;150-162.
73. Soliman EF, Slikker W Jr, Ali SF. Manganese-induced oxidative stress as measured by a fluorescent probe: in vitro study. Neurosci Res Comm 17:185-193 (1995).
74. Vitarella D, Struve MF, Goetz J, Ledford FI, Miller R, Dorman DC. Comparative neurotoxicity of oral manganese (II) chloride in neonatal and adult CD rats. In: 20th Annual Chemical Industry Institute of Toxicology Scientific Open House, 8 October, Research Triangle Park, NC. Research Triangle Park, NG:Chemical Industry Institute of Toxicology, 1996;46-47.
75. Kontur PJ, Fechter LD. Brain regional manganese levels and monoamine metabolism in manganese-treated neonatal rats. Neurotoxicol Teratol 10:295-303 (1988).
76. Seth PK, Chandra SV. Neurotransmitters and neurotransmitter receptors in developing and adult rats during manganese poisoning. Neurotoxicology 5:67-76 (1984).
77. Cotzias GC, Miller ST, Papavasiliou PS, Tang LC. Interactions between manganese and brain dopamine Med Clin North Am 60:729-738 (1976).
78. Bell JG, Keen CL, Lönnerdal B. Higher retention of manganese in suckling than in adult rats is not due to maturational differences in manganese uptake by rat small intestine. J Toxicol Environ Health 26:387-398 (1989).
79. Mena I. Manganese. In: Disorders of Mineral Metabolism (Bronner F, Coburn JW, eds). New York:Academic Press, 1981;233-270.
80. Dawson R Jr, Beal MF, Bondy SC, Di Monte DA, Isom GE. Excitotoxins, aging, and environmental neurotoxins: implications for understanding human neurodegenerative diseases. Toxicol Appl Pharmacol 134:1-17 (1995).
81. Desole MS, Esposito G, Migheli R, Fresu L, Sircana S, Zangani D, Miele M, Miele E. Cellular defence mechanisms in the striatum of young and aged rats subchronically exposed to manganese. Neuropharmacology 34:289-295 (1995).
82. Weiss B, Reuni K. Delayed neurotoxicity: a silent toxicity. In: Neurological Disease and Therapy. Vol 26: Principles of Neurotoxicology (Chang LW, ed). New York:Marcel Dekker, 1994;765-784.
83. Wennberg A. Neurotoxic effects of selected metals. Scand J Work Environ Health 20(Special Issue):65-71 (1994).
84. Smyth LT, Ruhf RC, Whitman NE, Dugan T. Clinical manganism and exposure to manganese in the production and processing of ferromanganese alloy. J Occup Med 15:101-109 (1973).
85. 2 dust. Neurotoxicology 5:119-131 (1984).
86. Archibald FS, Tyree C. Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch Biochem Biophys 256:638-650 (1987).
87. Donaldson J, McGregor D, LaBella F. Manganese neurotoxicity: a model for free radical mediated neurodegeneration? Can J Physiol Pharmacol 60:1398-1405 (1982).
88. +3. Neurodegeneration 4:329-334 (1995).
89. Oberdoerster G, Cherian G. Manganese. In: Biological Monitoring of Toxic Metals (Clarkson TW, Friber L, Nordberg GF, Sager PR, eds). New York:Plenum Press, 1988;283-301.
90. Drown DB, Oberg SG, Sharma RP. Pulmonary clearance of soluble and insoluble forms of manganese. J Toxicol Environ Health 17:201-212 (1986).
91. Komura J, Sakamoto M. Subcellular and gel Chromatographic distribution of manganese in the mouse brain: relation to the chemical form of chronically-ingested manganese. Toxicol Lett 66:287-294 (1993).
92. 1) on the absorption and cerebral distribution of manganese in rats. Arch Toxicol 71:223-230 (1997).
93. U.S. EPA. ORD's Response to Public Comments on Health and Exposure Issues in Relation to the Waiver Petition of Ethyl Corporation to Add Methylcyclopentadienyi Manganese Tricarbonyl (MMT) to Unleaded Gasoline. Washington:U.S. Environmental Protection Agency, 1994.
94. Gottschalk LA, Rebello T, Buchsbaum MS, Tucker HG, Hodges EL. Abnormalities in hair trace elements as indicators of aberrant behavior. Compr Psychiatry 32:229-237 (1991).
95. U.S. EPA. Summary of Workshop Discussions at the Manganese and Methylcyclopentadienyi Manganese Tricarbonyl (MMT) Conference, 12-15 March, Washington. Washington:U.S. Environmental Protection Agency, 1991.
96. 4) and Methylcyclopentadienyl Manganese Tricarbonyl (MMT). Washington:U.S. Environmental Protection Agency, 1991.
97. Shiotsuka RN. Inhalation toxicity of manganese dioxide and a magnesium oxide-manganese dioxide mixture. Army Project Order No 3803. Frederick, MD:U.S. Army Medical Research and Development Command, 1984.
98. Moore W, Hysell D, Miller R, Malanchuk M, Hinners R, Yang Y, Stara JF. Exposure of laboratory animals to atmospheric manganese from automotive emissions. Environ Res 9:274-284 (1975).
99. Lloyd Davies TA, Harding HE. Manganese pneumonias: further clinical and experimental observations. Br J Ind Med 6:82-90 (1949).
100. Nishiyama K, Suzuki Y, Fujii N, Yano H, Miyai T, Ohmishi K. Effect of long-term inhalation of manganese dusts. II: Continuous observation of the respiratory organs of monkeys and mice. Nihon Eiseigaku Zasshi 30:117 (1975).
101. 4) exposure on selected reproductive parameters in rats. J Toxicol Environ Health 9:677-687 (1982).
102. 2 in the adult mouse. Neurotoxicology 6:1-16 (1985).
103. Suzuki Y, Fujii N, Yano H, Ohkita T, Ichikawa A, Nishiyama K. Effects of the inhalation of manganese dioxide dust on monkey lungs. TokushimaJ Exp Med 25:119-125.
104. Eriksson H, Mägiste K, Plantin L-O, Fonnum F, Hedström K-G, Theodorsson-Norheim E, Kristensson K, Stalberg E, Heilbronn E. Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Arch Toxicol 61:46-52 (1987).
105. Roels H, Lauwerys R, Genet P, Sarhan MJ, de Fays M, Hanotiau I, Buchet J-P. Relationship between external and internal parameters of exposure to manganese in workers from a manganese oxide and salt producing plant. Am J Ind Med 11:297-305 (1987).
106. Gerhardsson L, Skerfving S. Concepts on biological markers and biomonitoring for metal toxicity. In: Toxicology of Metals (Chang LW, Magos L, Suzuki T, eds). Boca Raton, FL:CRC Lewis, 1996;81-107.